CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 185 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 7.73 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,225,078 | +29.6% | 396,280 | -21.9% | 0.36% | +29.3% |
| Q1 2023 | $11,748,903 | -11.6% | 507,512 | 0.0% | 0.28% | -12.5% |
| Q4 2022 | $13,296,814 | +33.3% | 507,512 | 0.0% | 0.32% | +24.0% |
| Q3 2022 | $9,978,000 | +12.4% | 507,512 | 0.0% | 0.26% | 0.0% |
| Q2 2022 | $8,876,000 | -22.5% | 507,512 | -27.5% | 0.26% | -10.4% |
| Q1 2022 | $11,458,000 | -2.5% | 700,349 | -2.8% | 0.29% | +6.3% |
| Q4 2021 | $11,749,000 | +33.8% | 720,349 | +4.7% | 0.27% | +46.5% |
| Q3 2021 | $8,781,000 | -8.9% | 688,149 | +0.8% | 0.18% | -2.6% |
| Q2 2021 | $9,636,000 | -7.9% | 682,449 | +1.4% | 0.19% | -16.7% |
| Q1 2021 | $10,459,000 | -1.4% | 673,049 | +0.6% | 0.23% | +1.3% |
| Q4 2020 | $10,608,000 | – | 668,849 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |